Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue
+7.64%
EPS
−12.4%
Free cash flow
−19.4%
Total debt
−10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%
Market cap
$127.6B
P/E
35.3×
Fwd P/E
24.6×
Dividend yield
1.05%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
ROE

+8 more TTM periods

15.08% 15.20% 16.51% 16.02%
Piotroski F-Score
5 7 7 8
ROA
7.15% 7.23% 7.91% 7.68%
ROIC
8.94% 8.97% 9.76% 9.67%
Return on Tangible Assets
29.95% 30.59% 31.89% 30.87%
Average Days of Receivables
58.70 51.58 52.88 51.25
Free Cash Flow per Share
11.21 11.94 12.26 11.53
Free Cash Flow
4,283.00 4,571.00 4,702.00 4,408.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026